Clinical trial
Phase II Study of MEDI4736 Monotherapy in the Treatment of Patients With Recurrent or Metastatic SCCHN.
Primary Objective: To assess the efficacy of MEDI4736 monotherapy in terms of ORR
| Category | Value |
|---|---|
| Study start date | 2014-08-01 |